Background: Kidney transplant (Tx) restores renal filtration, although it does not achieve the function of two native kidneys, and with time it may variably involute back to chronic renal failure. We hypothesized that bioelectrical impedance analysis (BIA) might highlight differences for body compartments among Tx with different filtration rates, and we compared them with healthy controls. Methods: 38 Tx patients (25 males, 13 females) were studied at 75.9 ± 37.8 months postsurgery and divided into three groups: good creatinine clearance (CrCl, ml/min/1.73 m2; > 65.0), borderline (35.0 < CrCl < 60.0) and bad (CrCl < 35.0). BIA was assessed three times in a year. Total body water, extracellular water (ECW), intracellular water (ICW), Na:K exchange rate (Nae:Ke) and phase angle were studied. Healthy (n = 11) and hemodialysis (n = 11) groups were also studied. Results: BIA showed no differences between healthy controls and good Tx while both borderline and bad Tx presented a significantly higher ECW and lower ICW than either good Tx or normal controls. Only good CrCl was different from predialysis. Conclusions: A good kidney graft manages to restore and maintain normal body composition, even with potential disturbances brought about by steroids and cyclosporine. With mild renal dysfunction a change in body compartments was observed, moving towards the composition of that with chronic renal failure patients.

1.
Verran D, Munn S, Collins J, et al: Impact of renal allograft implantation and immunosuppression on body composition using in vivo neutron activation analysis. Transpl Proc 1992;24:173–174.
2.
Guarnieri G, Toigo G, Fiotti N, et al: Mechanisms of malnutrition in uremia. Kidney Int 1997;52(suppl):41–44.
3.
Dumler F, Kilates C: Nutritional status assessment and body composition analysis in pre-end-stage renal disease patients. Miner Electrolyte Metab 1999;25:397–399.
4.
Ishimura E, Okuno S, Kim M, et al: Increasing body fat mass in the first year of hemodialysis. J Am Soc Nephrol 2001;12:1921–1926.
5.
Foley RN, Parfrey PS, Harnett JD, et al: Hypoalbuminenia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996;7:728–736.
6.
Pupim L, Kent P, Ikizler A: Bioelectrical impedance analysis in dialysis patients. Miner Electrolyte Metab 1999;25:400–406.
7.
O’Sullivan A, Lawson J, Chan M, et al: Body composition and energy metabolism in chronic renal insufficiency. Am J Kidney Dis 2002;39:369–375.
8.
Lowrie EG, Zhu XH, Lew NL: Primary associates of mortality among dialysis patients: trends and reassessment of Kt/V and urea reduction ratio as outcome-based measures of dialysis dose. Am J Kidney Dis 1998;32(suppl):16–31.
9.
Chen YC, Chen HH, Yeh JC, et al: Adjusting dry weight by extracellular volume and body composition in hemodialysis patients. Nephron 2002;92:91–96.
10.
Dumler F, Schmidt R, Kilates C, et al: Use of bioelectrical impedance for the nutritional assessment of chronic hemodialysis patients. Miner Electrolyte Metab 1992;18:284–287.
11.
Baumgartner RN: Electrical impedance and total body electrical conductivity, in Roche AF, Heymsfield SB, Lohman TG (eds): Human Body Composition. Champaign, Human Kinetics, 1996, pp 79–94.
12.
Chertow GM, Jacobs DO, Lazarus JM, Lew NL, Lowrie EG: Phase angle predicts survival in hemodialysis patients. J Ren Nutr 1997;7:204–207.
13.
Kyle UG, Genton L, Karsegard VL, et al: Percentiles (10, 25, 75 and 90th) for phase angle, determined by bioelectrical impedance, in 2,740 healthy adults aged 20–75 years. Clin Nutr 2004;23:758.
14.
Maggiore Q, Nigrelli S, Ciccarelli C, et al: Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 1996;50:2103–2108.
15.
Mushnick R, Fein PA, Mittman N, et al: Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients. Kidney Int 2003;64(suppl 87):53–56.
16.
Kushner RF, Gudivaka R, Dale S: Clinical characteristics influencing bioelectrical Impedance analysis measurements. Am J Clin Nutr 1996;64(suppl):423–427.
17.
Garrow JS: Composition of the body; in Garrow JS, James WPT, Ralph A (eds): Human Nutrition and Dietetics. Edinburgh, Churchill Livingstone, 2000, pp 19–20.
18.
Lee RD, Nieman DC: Anthropometry, in Lee RD, Nieman DC (eds): Nutritional Assessment. St Louis, Mosby, 1996, pp 272–273.
19.
Gibson RS: Laboratory assessment of body composition, in Gibson RS (ed): Principles of Nutritional Assessment. New York, Oxford University Press, 1990, pp 277–278.
20.
Chertow G, Lazarus JM, Lew NL, et al: Bioimpedance norms for the hemodialysis population. Kidney Int 1997;52:1617–1621.
21.
Kemperman FA, Surachno J, Krediet R, et al: Cimetidine improves prediction of the glomerular filtration rate by the Cockroft-Gault formula in renal transplant recipients. Transplantation 2002;73:770–774.
22.
Rose BD: The total body water and the plasma sodium concentration; in Rose BD, Post TW (eds): Clinical Physiology of Acid-Base and Electrolyte Disorders. New York, McGraw-Hill, 2001, pp 241–246.
23.
Van den Ham E, Kooman J, van Hooff J: Nutritional considerations in renal transplant patients. Blood Purif 2002;20:139–144.
24.
Fellström B: Impact and management of hyperlipidemia posttransplantation. Transplantation 2000;70(suppl):51–57.
25.
Kouw PM, Olthof CG, Wee PM, et al: Assessment of post-dialysis dry weight: an application of the conductivity measurement method. Kidney Int 1992;41:440–441.
26.
Jaeger JQ, Mehta RL: Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999;10:392–403.
27.
Dumler F, Kilates C: Use of bioelectrical impedance techniques for monitoring nutritional status in patients on maintenance hemodialysis. J Ren Nutr 2000;10:116–124.
28.
Van den Ham E, Kooman J, Christiaans M, et al: Body composition in renal transplant patients: bioimpedance analysis compared to isotope dilution, dual energy x-ray absorptiometry, and anthropometry. J Am Soc Nephrol 1999;10:1067–1079.
29.
Vasdev S, Johnson E, Longerich L, et al: Plasma endogenous digitalis-like factors in healthy individuals and in dialysis dependent and kidney transplant patients. Clin Nephrol 1987;27:169–174.
30.
Bresticker M, Nelson J, Huang C, et al: Plasma renin activity in renal transplant patients with hypertension. Am J Hypertens 1991;4:623–626.
31.
Coroas A, Oliveira JGG, Sampaio S, et al: Renal transplant versus hemodialysis: which differences? J Am Soc Nephrol 2001;12:324P.
32.
Coroas A, Oliveira JGG, Sampaio S, et al: Cyclosporine enhances salt sensitivity of body water composition as assessed by impedance among psoriatic patients with normal renal function. J Ren Nutr 2004;14:226–232.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.